Intelligence Driven Advisers’s iShares US Medical Devices ETF IHI Stock Holding History

Intelligence Driven Advisers’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,660	Closed	-$414K	–	141
2025 Q4	$414K	Hold	6,660	–	–	0.06%	80
2025 Q3	$400K	Hold	6,660	–	–	0.06%	75
2025 Q2	$417K	Buy	+6,660	New	+$400K	0.06%	74
2023 Q1	–	Sell	-4,157	Closed	-$222K	–	96
2022 Q4	$222K	Sell	4,157 -13,606	-77%	-$690K	0.04%	92
2022 Q3	$883K	Sell	17,763 -136,394	-88%	-$7.08M	0.18%	61
2022 Q2	$7.92M	Sell	154,157 -1,035	-0.7%	-$56.4K	1.55%	24
2022 Q1	$9.65M	Buy	155,192 +3,282	+2%	+$196K	1.76%	18
2021 Q4	$8.79M	Sell	151,910 -166	-0.1%	-$10.6K	1.61%	21
2021 Q3	$9.46M	Sell	152,076 -5,544	-4%	-$354K	2.12%	17
2021 Q2	$9.48M	Sell	157,620 -118,980	-43%	-$6.88M	1.84%	19
2021 Q1	$15.2M	Buy	276,600 +4,854	+2%	+$269K	3.42%	10
2020 Q4	$14.8M	Buy	271,746 +1,026	+0.4%	+$53.6K	3.32%	11
2020 Q3	$13.5M	Buy	+270,720	New	+$13.1M	3.17%	14

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Intelligence Driven Advisers's IHI Position: Q1 2026 in Review

Intelligence Driven Advisers sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 6,660 shares — an estimated $414K sold.

Intelligence Driven Advisers first reported a position in IHI in Q3 2020 and held it in 13 quarters. The position peaked at $15.2M in Q1 2021. 510 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Intelligence Driven Advisers reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
Intelligence Driven Advisers sold 6,660 iShares US Medical Devices ETF shares in Q1 2026, an estimated $414K.
Intelligence Driven Advisers first reported a position in iShares US Medical Devices ETF in Q3 2020 and held it in 13 quarters.
Intelligence Driven Advisers's iShares US Medical Devices ETF position peaked at $15.2M in Q1 2021.
510 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Intelligence Driven Advisers's 13F filing for Q1 2026, filed 15 May 2026.